Design and Synthesis of New 1,3‐Benzdiazinan‐4‐one Derivatives as Selective Cyclooxygenase (COX‐2) Inhibitors

A. Zarghi,Tannaz Zebardast,F. Hajighasemali,Eskandar Alipoor,Bahram Daraie,M. Hedayati
DOI: https://doi.org/10.1002/ardp.201100138
2012-04-01
Archiv der Pharmazie
Abstract:A new group of regioisomeric 2,3‐diaryl‐1,3‐benzdiazinan‐4‐ones, possessing a methyl sulfonyl pharmacophore, were synthesized and their biological activities were tested for cyclooxygenase‐2 (COX‐2) inhibitory activity. In vitro COX‐1/COX‐2 inhibition studies identified 3‐(p‐fluorophenyl)‐2‐(4‐methylsulfonylphenyl)‐1,3‐benzdiazinane‐4‐one (2b) as a potent and highly selective (IC50 = 0.07 µM; selectivity index = 572.8) COX‐2 inhibitor.
What problem does this paper attempt to address?